Module 5 - DSTB Treatment

DSTB Treatment

Module 5

Multiple Choice

What is the primary factor to consider in choosing a treatment regimen for DSTB?

• a. History of treatment

• b. Severity of the TB disease

• c. Result of drug susceptibility testing/Xpert MTB/RIF test

• d. Age of the patient

Multiple Choice

Which regimen is appropriate for a patient who previously completed treatment for DSTB (6 months on Regimen 1) and comes back with symptoms of PTB and Xpert result of MTB detected, Rifampicin susceptible?

• a. 2HRZE/4HR

• b. DRTB regimen

• c. 2HRZES/1HRZE/5HRE

• d. 6HRZE

Multiple Choice

What is the registration group of a patient who has never had previous treatment for tuberculosis or treated but less than 1 month?

• a. Relapse

• b. New

• c. Treatment Failure

• d. Treatment after loss to follow-up

Multiple Choice

What is the registration group classification[TB1] of a patient who previously had incomplete treatment for TB, only 3 months, and comes back with bacteriologically confirmed TB?

[TB1]Same comment as above

• a. Relapse

• b. New

• c. Treatment Failure

• d. Treatment after loss to follow-up

Multiple Choice

Once a regimen is assigned, which factor is considered to determine the dosage of drugs to be given?

• a. Sex

• b. Site of disease

• c. Weight

• d. History of treatment

Multiple Choice

How many calendar days per month are used to determine drug requirements for the entire duration of DSTB treatment?

• a. Actual days per month

• b. 30 days

• c. 31 days

• d. 28 days

Multiple Choice

Which can be a treatment supporter for TB patients?

• a. Health worker

• b. Family member

• c. Community volunteer

• d. All of the above

Multiple Choice

When should a sputum follow-up examination (smear microscopy) be requested for a new clinically diagnosed TB case?

• a. End of 2 months only, as long as its negative

• b. End of 2 months, 5^th month, 6^th month

• c. No follow-up required

• d. None of the above

Multiple Choice

If a second month smear microscopy follow-up result is positive, what should be the next course of action?

• a. Declare it as failed treatment

• b. Do/Repeat Xpert MTB/Rif[PD1] , continue treatment meantime

  [PD1]Xpert MTB/Rif Test

• c. Discontinue treatment and request for TBC and DST

• d. Extend intensive phase for 1 month and repeat DSSM after the 3^rd month

Multiple Choice

Once a regimen is assigned, which factor is considered to determine the dosage of drugs to be given?

• a. Sex

• b. Site of disease

• c. Weight

• d. History of treatment